What is Vikand?
VIKAND stands as the premier provider of comprehensive medical management and consulting services tailored specifically for the maritime industry. By integrating concierge-level medical support with advanced technological solutions, the company effectively mitigates the operational risks associated with fragmented vendor landscapes. Their service portfolio includes 24/7 on-call medical expertise and the deployment of the Hygensea Odorox system, an FDA-approved technology that utilizes hydroxyl generators to neutralize pathogens, odors, and contaminants in air and on surfaces. This dual-pronged approach of human-centric medical management and environmental health technology positions VIKAND as an essential partner for large-scale maritime enterprises.
How much funding has Vikand raised?
Vikand has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Vikand
PPP
Public-Private Partnership
What's next for Vikand?
With this late-stage financing, VIKAND is well-positioned to accelerate its market penetration and expand its technological footprint across the global maritime sector. The strategic focus will likely shift toward deepening the integration of its medical management platforms and scaling the distribution of its proprietary air and surface purification systems. By leveraging this capital, the company aims to further streamline the complexities of maritime medical logistics, potentially exploring new partnerships or service expansions that address the evolving regulatory and health-safety demands of the offshore and cruise industries. The firm's ability to consolidate fragmented medical services into a unified, high-efficiency model remains its primary competitive advantage as it enters this next phase of growth.
See full Vikand company page
